| Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles LS Cohen, CN Soares, AF Vitonis, MW Otto, BL Harlow Archives of general psychiatry 63 (4), 385-390, 2006 | 1101 | 2006 |
| Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial C de Novaes Soares, OP Almeida, H Joffe, LS Cohen Archives of general psychiatry 58 (6), 529-534, 2001 | 919 | 2001 |
| Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability? CN Soares, B Zitek Journal of Psychiatry and Neuroscience 33 (4), 331-343, 2008 | 478 | 2008 |
| Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles BL Harlow, LA Wise, MW Otto, CN Soares, LS Cohen Archives of general psychiatry 60 (1), 29-36, 2003 | 340 | 2003 |
| Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report LS Cohen, CN Soares, JR Poitras, J Prouty, AB Alexander, JL Shifren American Journal of Psychiatry 160 (8), 1519-1522, 2003 | 284 | 2003 |
| Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care H Joffe, JE Hall, CN Soares, J Hennen, CJ Reilly, K Carlson, LS Cohen Menopause 9 (6), 392-398, 2002 | 274 | 2002 |
| Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women: the Harvard study of moods and cycles LS Cohen, CN Soares, MW Otto, BH Sweeney, RF Liberman, BL Harlow Journal of affective disorders 70 (2), 125-132, 2002 | 267 | 2002 |
| Depression in women: windows of vulnerability and new insights into the link between estrogen and serotonin S Lokuge, BN Frey, JA Foster, CN Soares, M Steiner The Journal of clinical psychiatry 72 (11), 3297, 2011 | 183 | 2011 |
| Postpartum onset obsessive-compulsive disorder: diagnosis and management M Brandes, CN Soares, LS Cohen Archives of Women’s Mental Health 7, 99-110, 2004 | 176 | 2004 |
| MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes JP Lopez, LM Fiori, C Cruceanu, R Lin, B Labonte, HM Cates, EA Heller, ... Nature communications 8 (1), 15497, 2017 | 170 | 2017 |
| Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations PM Maki, SG Kornstein, H Joffe, JT Bromberger, EW Freeman, ... Journal of women's health 28 (2), 117-134, 2019 | 161 | 2019 |
| Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms CN Soares, JR Poitras, J Prouty, AB Alexander, JL Shifren, LS Cohen Journal of Clinical Psychiatry 64 (4), 473-479, 2003 | 161 | 2003 |
| Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri-and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life CN Soares, H Arsenio, H Joffe, B Bankier, P Cassano, LF Petrillo, ... Menopause 13 (5), 780-786, 2006 | 159 | 2006 |
| The Premenstrual Symptoms Screening Tool revised for adolescents (PSST-A): prevalence of severe PMS and premenstrual dysphoric disorder in adolescents M Steiner, M Peer, E Palova, EW Freeman, M Macdougall, CN Soares Archives of women's mental health 14, 77-81, 2011 | 151 | 2011 |
| Diagnosis and management of mood disorders during the menopausal transition LS Cohen, CN Soares, H Joffe The American Journal of Medicine 118 (12), 93-97, 2005 | 147 | 2005 |
| Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations PM Maki, SG Kornstein, H Joffe, JT Bromberger, EW Freeman, ... Menopause 25 (10), 1069-1085, 2018 | 141 | 2018 |
| Mood disorders in midlife women: understanding the critical window and its clinical implications CN Soares Menopause 21 (2), 198-206, 2014 | 139 | 2014 |
| Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first … RW Lam, R Milev, S Rotzinger, AC Andreazza, P Blier, C Brenner, ... BMC psychiatry 16, 1-13, 2016 | 138 | 2016 |
| Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial CN Soares, H Joffe, R Rubens, J Caron, T Roth, L Cohen Obstetrics & Gynecology 108 (6), 1402-1410, 2006 | 137 | 2006 |
| Physical activity and health during the menopausal transition B Sternfeld, S Dugan Obstetrics and Gynecology Clinics 38 (3), 537-566, 2011 | 136 | 2011 |
Benicio N. Frey, MD, PhD, FRCPCDepartment of Psychiatry and Behavioural Neurosciences, McMaster UniversityVerified email at mcmaster.ca
